Vincerx Pharma Inc (VINC)
0.6944
-0.03
(-3.56%)
USD |
NASDAQ |
May 17, 16:00
0.6944
0.00 (0.00%)
After-Hours: 20:00
Vincerx Pharma Shareholders Equity (Quarterly): -0.622M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.622M |
| December 31, 2023 | 11.22M |
| September 30, 2023 | 15.74M |
| June 30, 2023 | 24.14M |
| March 31, 2023 | 34.47M |
| December 31, 2022 | 47.67M |
| September 30, 2022 | 59.71M |
| Date | Value |
|---|---|
| June 30, 2022 | 74.36M |
| March 31, 2022 | 89.17M |
| December 31, 2021 | 100.32M |
| September 30, 2021 | 100.63M |
| June 30, 2021 | 71.60M |
| March 31, 2021 | 25.55M |
| December 31, 2020 | 25.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.622M
Minimum
Mar 2024
100.63M
Maximum
Sep 2021
48.52M
Average
41.07M
Median
Shareholders Equity (Quarterly) Benchmarks
| Trxade Health Inc | 0.5424M |
| MyMD Pharmaceuticals Inc | 12.37M |
| Acrivon Therapeutics Inc | 107.98M |
| Ligand Pharmaceuticals Inc | 806.52M |
| Regulus Therapeutics Inc | 107.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.08M |
| Total Liabilities (Quarterly) | 11.70M |